Guardian Pharmacy Services Inc

Guardian Pharmacy Services Inc(GRDN)股票分析

$39.190

-0.247 (-0.63%)收盘时

Loading chart…
最高
40.170
开盘
39.740
成交量加权均价
39.40
成交量
212.14K
市值
—
最低
38.855
成交额
8.36M
企业价值/息税折旧摊销前利润(TTM)
31.97

Guardian Pharmacy Services, Inc. is a pharmacy services company. The Company provides a range of technology-enabled services designed to help residents of long-term care facilities (LTCFs) adhere to drug regimen. It offers compliance packaging service for repackaging and dispensing prescription and non-prescription pharmaceuticals in accordance with physician orders and delivers the medications to LTCFs for administration to individual residents. It organizes each resident’s medications into individual unit dose or multi-unit dose packaging in accordance with specific drug distribution rounds that occur at LTCFs at specific times throughout the day. Its pharmacy workflow software helps to manage and track drug dispensing via a structured and scalable workflow process, including the use of barcode technology. It offers Guardian Compass, which includes dashboards created to help local pharmacies plan, track and optimize business operations.

AI 分析 of Guardian Pharmacy Services Inc (GRDN)

买入

Guardian Pharmacy Services Inc is a good buy right now, trading at $39.44, which is significantly below the analyst consensus target of $49.81. The stock has shown strong growth, with a year-to-date change of +33.56% and a 1-year change of +35.77%. The forward P/E ratio of 30.21 suggests reasonable growth expectations, while the gross margin has improved to 22.75%. However, the RSI is at 42.11, indicating it is nearing oversold territory, which could present a buying opportunity.

估值指标

Guardian Pharmacy Services Inc(GRDN)当前预期市盈率为 30.21,5 年平均预期市盈率为 26.72。

预期市盈率

合理
5 年均值 P/E
26.72
当前P/E
30.21
高估
30.56
低估
22.89

预期 EV/EBITDA

严重高估
5 年均值 EV/EBITDA
18.33
当前EV/EBITDA
31.97
高估
24.05
低估
12.61

预期市销率

高估
5 年均值 P/S
1.27
当前P/S
1.64
高估
1.55
低估
0.99

持有 GRDN 的大户

A

Aristotle Capital Boston, LLC

+ 持有GRDN

-0.91%

3个月收益率

事件时间线

2026-09-01 (ET)

17:00:00

Guardian Pharmacy Acquires Assets from Nautilus Pharmacy

2026-08-06 (ET)

17:01:00

Guardian Reports Q2 Revenue of $351.8M, Beating Expectations

17:01:00

Raises FY26 Adjusted EBITDA View to $129M-$131M

2026-07-01 (ET)

17:00:00

Guardian Pharmacy Acquires Wellness Concepts to Expand Virginia Operations

2026-06-22 (ET)

17:00:00

Guardian Pharmacy Executive Forbes Retires, Morris to Become COO

资讯

GRDN 常见问题 —— 由 Alphio AI 解答

Guardian Pharmacy Services, Inc. is a pharmacy services company. The Company provides a range of technology-enabled services designed to help residents of long-term care facilities (LTCFs) adhere to drug regimen. It offers compliance packaging service for repackaging and dispensing prescription and non-prescription pharmaceuticals in accordance with physician orders and delivers the medications to LTCFs for administration to individual residents. It organizes each resident’s medications into individual unit dose or multi-unit dose packaging in accordance with specific drug distribution rounds that occur at LTCFs at specific times throughout the day. Its pharmacy workflow software helps to manage and track drug dispensing via a structured and scalable workflow process, including the use of barcode technology. It offers Guardian Compass, which includes dashboards created to help local pharmacies plan, track and optimize business operations. It operates in the Consumer Non-Cyclicals sector.

Guardian Pharmacy Services Inc is a good buy right now, trading at $39.44, which is significantly below the analyst consensus target of $49.81. The stock has shown strong growth, with a year-to-date change of +33.56% and a 1-year change of +35.77%. The forward P/E ratio of 30.21 suggests reasonable growth expectations, while the gross margin has improved to 22.75%. However, the RSI is at 42.11, indicating it is nearing oversold territory, which could present a buying opportunity.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易